Aaron Wallace
Overview
Explore the profile of Aaron Wallace including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farahani M, Tindyebwa T, Sugandhi N, Ward K, Park Y, Bakkabulindi P, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39772015
Uganda's Integrated Child Health Day (ICHD) initiative aims to improve children's access to vaccinations. Although widely used as a catch-up vaccination strategy, the effectiveness of the ICHD program in increasing...
2.
Crowcroft N, Minta A, Antoni S, Ho L, Perea W, Mulders M, et al.
Rev Panam Salud Publica
. 2024 Dec;
48():e90.
PMID: 39687257
Measles and rubella have long been recognized as priorities for disease prevention because of their devastating consequences for child health; hence, all World Health Organization (WHO) regions currently have a...
3.
Jones C, Danovaro-Holliday M, Mwinnyaa G, Gacic-Dobo M, Francis L, Grevendonk J, et al.
MMWR Morb Mortal Wkly Rep
. 2024 Oct;
73(43):978-984.
PMID: 39480752
In 2020, the World Health Assembly endorsed the Immunization Agenda 2030 (IA2030), a 10-year strategy to reduce vaccine-preventable disease (VPD)-associated morbidity and mortality. IA2030 goals include improving equitable vaccination coverage,...
4.
Grace P, Peters J, Sixsmith J, Lu R, Luedeman C, Fenderson B, et al.
bioRxiv
. 2024 Oct;
PMID: 39416184
the causative agent of tuberculosis (TB), is a leading cause of death by an infectious disease globally, with no efficacious vaccine. Antibodies are implicated in control, but the mechanisms of...
5.
Irvine E, Nikolov A, Khan M, Peters J, Lu R, Sixsmith J, et al.
Nat Microbiol
. 2024 Aug;
9(9):2369-2382.
PMID: 39174703
Mounting evidence indicates that antibodies can contribute towards control of tuberculosis (TB). However, the underlying mechanisms of humoral immune protection and whether antibodies can be exploited in therapeutic strategies to...
6.
Woyessa A, Shah M, Azmeraye B, Pan J, Lisanwork L, Yimer G, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066400
Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia's routine immunization program since 1980. A second dose of MCV (MCV2) was introduced...
7.
Solomon K, Aksnes B, Woyessa A, Geri C, Sadi C, Matanock A, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066340
Ethiopia introduced a second dose of measles-containing vaccine (MCV2) in 2019 to provide further protection against measles and further progress toward elimination. However, the sub-optimal coverage of both MCV1 and...
8.
Kaur G, Danovaro-Holliday M, Mwinnyaa G, Gacic-Dobo M, Francis L, Grevendonk J, et al.
MMWR Morb Mortal Wkly Rep
. 2023 Oct;
72(43):1155-1161.
PMID: 37883326
In 2020, the World Health Assembly endorsed the Immunization Agenda 2030 (IA2030), the 2021-2030 global strategy that envisions a world where everyone, everywhere, at every age, fully benefits from vaccines....
9.
Nambiar D, Hosseinpoor A, Bergen N, Danovaro-Holliday M, Wallace A, Johnson H
Vaccines (Basel)
. 2023 May;
11(5).
PMID: 37243017
Immunization, hailed as one of the most successful public health interventions in the world, has contributed to major advancements in health as well as social and economic development [...].
10.
Wallace A, Kaufmann G, Agrawal N, Baroody F
J Craniofac Surg
. 2023 Jan;
34(3):e252-e254.
PMID: 36617675
The authors present an interesting case of ganglioneuroblastoma, a tumor of the sympathetic chain, presenting as severe obstructive sleep apnea in a healthy 5-year-old boy. The patient's initial polysomnogram demonstrated...